TP53 and head and neck cancer: PD-L1 expression has been shown to correlate with favorable prognosis in several human solid malignancies, including head and neck cancer [50,51], consistent with the better prognosis of p53 WT human head and neck cancers, and with the longer survival rates of p53 WT mice compared to mice with p53 mutations found in this study.